The Role Of Du Testing In Scaling Down The Burden Of Rhesus-D Negative Transfusion In Northern Nigeria
The Internet Journal of Third World Medicine · 2009
DOI: 10.5580/11b5 ↗At a glance
Journal article in The Internet Journal of Third World Medicine, 2009. Cited 2 times so far (Crossref).
Abstract (original language)
The low frequency of RhD negativity in Nigeria coupled with a sub-optimal national blood transfusion service has resulted in scarcity of RhD negative blood in Nigerian blood banks. This study was conducted to determine the frequency of D antigen among RhD negative patients scheduled for transfusion with the aim of scaling down the burden of RhD negative transfusion in northern Nigeria. The RhD groups of 2978 patients that were scheduled for transfusion were determined. Samples that were RhD negative were further tested for the D antigen. A total of 2897 (97.3%) samples were RhD positive while 81 (2.7%) samples were RhD negative. Out of the 81 RhD negative samples, 4 (4.9%) were D positive while the remaining 77 (95.1%) samples were D negative. Therefore, the D test may be used to scale down the burden of RhD negative transfusion by 4.9% in northern Nigeria.
Cite
APA
(2009). The Role Of Du Testing In Scaling Down The Burden Of Rhesus-D Negative Transfusion In Northern Nigeria. The Internet Journal of Third World Medicine. https://doi.org/10.5580/11b5
Vancouver
The Role Of Du Testing In Scaling Down The Burden Of Rhesus-D Negative Transfusion In Northern Nigeria. The Internet Journal of Third World Medicine. 2009. doi:10.5580/11b5
BibTeX
@article{euvimed2009,
title = {The Role Of Du Testing In Scaling Down The Burden Of Rhesus-D Negative Transfusion In Northern Nigeria},
journal = {The Internet Journal of Third World Medicine},
year = {2009},
doi = {10.5580/11b5}
}
EUVIMED